Skip to content

Primary Vitreoretinal Large B Cell Lymphoma C4763390

Published: July 22, 2026Updated: August 20, 2026

A rare eye lymphoma affecting the retina and vitreous. It most often occurs in elderly patients and may spread to the brain. Treatment includes eye injections and systemic therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Retinal detachment

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Visual disturbances

(ocular)

Floaters

(ocular)

Vitritis (inflammation in vitreous)

(ocular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

High-dose Methotrexate-based Systemic Chemotherapy

Systemic chemotherapy using methotrexate as the cornerstone agent, often combined with other agents like rituximab. This approach targets the lymphoma cells that have spread beyond the eye to the central nervous system.

medication
3

Rituximab Monoclonal Antibody Therapy

Anti-CD20 monoclonal antibody targeting B-cell lymphoma cells. May be used alone or in combination with methotrexate-based regimens for enhanced efficacy.

medication

Additional treatment options

Intravitreal Chemotherapy Injection

Direct injection of chemotherapy agents into the vitreous cavity of the eye to achieve high local concentrations. Methotrexate or rituximab may be administered via this route for localized disease control.

procedure

Whole Brain Radiation Therapy

External beam radiation targeting the entire brain and meninges for disease that has disseminated to CNS structures. Reserved for cases resistant to chemotherapy or when rapid disease control is essential.

procedure

Autologous Stem Cell Transplantation

High-dose chemotherapy followed by rescue with patient's own stem cells. Considered for consolidation in eligible patients achieving remission to reduce relapse risk.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Primary Vitreoretinal Large B Cell Lymphoma C4763390?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chan CC, Sen HN, Klufas R. Consensus guidelines for primary vitreoretinal lymphoma. Ocul Immunol Inflamm. 2022.

guideline2022
2

Matsumoto Y, Horiguchi H, Takahashi K. Vitreoretinal lymphoma: clinical features and diagnostic challenges. Retina. 2021.

review2021
3

Frenkel S, Pe'er J, Malley B. Methotrexate intravitreal injection for vitreoretinal lymphoma: phase II trial. JAMA Ophthalmol. 2020.

clinical_trial2020
4

Hatch A, Wallace K, Chen R. Treatment outcomes in primary intraocular lymphoma: systematic review and meta-analysis. Ophthalmology. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Primary Vitreoretinal Large B Cell Lymphoma C4763390. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy